These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 15840028)

  • 1. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
    Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
    Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
    Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD
    Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
    Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
    Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha.
    Karkar AM; Smith J; Pusey CD
    Nephrol Dial Transplant; 2001 Mar; 16(3):518-24. PubMed ID: 11239025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
    Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
    Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
    Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
    J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis.
    Tam FW; Smith J; Agarwal S; Karkar AM; Morel D; Thompson EM; Pusey CD
    Nephron; 2000 Jan; 84(1):58-66. PubMed ID: 10644909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking VLA-4 prevents progression of experimental crescentic glomerulonephritis.
    Khan SB; Allen AR; Bhangal G; Smith J; Lobb RR; Cook HT; Pusey CD
    Nephron Exp Nephrol; 2003; 95(3):e100-10. PubMed ID: 14646362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
    Liu D; Nazneen A; Taguchi T; Razzaque MS
    Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
    Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
    Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
    Tang WW; Feng L; Vannice JL; Wilson CB
    J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
    Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
    J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats.
    Iseri K; Iyoda M; Ohtaki H; Matsumoto K; Wada Y; Suzuki T; Yamamoto Y; Saito T; Hihara K; Tachibana S; Honda K; Shibata T
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1182-91. PubMed ID: 27053690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubulointerstitial nephritis and glomerulonephritis in Brown-Norway rats immunized with heterologous glomerular basement membrane.
    Robertson JL; Hill GS; Rowlands DT
    Am J Pathol; 1977 Jul; 88(1):53-68. PubMed ID: 879271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.
    Reynolds J; Khan SB; Allen AR; Benjamin CD; Pusey CD
    Kidney Int; 2004 Oct; 66(4):1444-52. PubMed ID: 15458437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
    Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
    Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of neutralizing antibodies on cytokine treatment for anti-GBM nephritis in mouse].
    Hattori T; Fujitsuka N; Kurogi A; Shindo S
    Nihon Jinzo Gakkai Shi; 1996 Dec; 38(12):563-70. PubMed ID: 9014475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice.
    Le Hir M; Haas C; Marino M; Ryffel B
    Lab Invest; 1998 Dec; 78(12):1625-31. PubMed ID: 9881962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.